{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:07:03Z","timestamp":1777626423246,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_133657"],"award-info":[{"award-number":["PP00P3_133657"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_159269"],"award-info":[{"award-number":["PP00P3_159269"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jtcvs.2019.07.073","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:22:49Z","timestamp":1566472969000},"page":"330-340.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial"],"prefix":"10.1016","volume":"159","author":[{"given":"Isabelle","family":"Opitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Lauk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayura","family":"Meerang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Jetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"Aeschlimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhardt","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf A.","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2019.07.073_bib1","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib5","first-page":"781","article-title":"Pleurectomy\/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma","volume":"56","author":"Colaut","year":"2004","journal-title":"Chir Ital"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jtcvs.2009.02.046","article-title":"Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study","volume":"138","author":"Tilleman","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","article-title":"Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma","volume":"24","author":"Richards","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1200\/JCO.1994.12.6.1156","article-title":"A phase II trial of pleurectomy\/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma","volume":"12","author":"Rusch","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0003-4975(94)91066-9","article-title":"Aggressive multimodality therapy for malignant pleural mesothelioma","volume":"58","author":"Rice","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.1992.10.6.1001","article-title":"Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies","volume":"10","author":"Rusch","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-5223(99)70297-7","article-title":"Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study","volume":"117","author":"Ratto","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1378\/chest.121.2.480","article-title":"Cytoreductive surgery and intraoperative\u00a0hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma","volume":"121","author":"de Bree","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1245\/ASO.2003.03.022","article-title":"Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma","volume":"10","author":"van Ruth","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/14712598.2014.897323","article-title":"Fibrin sealants: surgical hemostat, sealant and adhesive","volume":"14","author":"Mandell","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jtcvs.2008.02.079","article-title":"Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study","volume":"136","author":"Moser","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ejcts.2007.01.047","article-title":"Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment","volume":"31","author":"Opitz","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jtcvs.2005.08.012","article-title":"Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma","volume":"131","author":"Lardinois","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jtcvs.2010.09.032","article-title":"Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study","volume":"141","author":"Opitz","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/icvts\/ivw422","article-title":"Propensity matched comparison of extrapleural pneumonectomy and pleurectomy\/decortication for mesothelioma patients","volume":"24","author":"Kostron","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0003-2670(01)01041-8","article-title":"Trace analysis of platinum in biological samples: a comparison between sector field ICP-MS and adsorptive cathodic stripping voltammetry following different digestion procedures","volume":"439","author":"Zimmermann","year":"2001","journal-title":"Analytica Chimica Acta"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1023\/A:1015939917646","article-title":"Estimation of bioavailability on a single occasion after semisimultaneous drug administration","volume":"6","author":"Karlsson","year":"1989","journal-title":"Pharm Res"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib22","first-page":"437","article-title":"Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed","volume":"37","author":"Cortes-Dericks","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00280-007-0500-1","article-title":"Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma","volume":"61","author":"Gordon","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7819-7-14","article-title":"Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer","volume":"7","author":"Guardiola","year":"2009","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-007-0484-x","article-title":"Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer","volume":"61","author":"Royer","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib27","doi-asserted-by":"crossref","first-page":"471205","DOI":"10.1155\/2012\/471205","article-title":"Pharmacokinetics of hyperthermic intrathoracic chemotherapy following pleurectomy and decortication","volume":"2012","author":"Sugarbaker","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jtcvs.2008.07.055","article-title":"A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma","volume":"137","author":"Zellos","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/030089169608200111","article-title":"Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma","volume":"82","author":"Colleoni","year":"1996","journal-title":"Tumori"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ejcts\/ezs418","article-title":"Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience","volume":"43","author":"Ried","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/11317280-000000000-00000","article-title":"Population pharmacokinetics and dosing recommendations for cisplatin during intraperitoneal peroperative administration","volume":"48","author":"Ehrsson","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib32","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/JTO.0b013e3181ae25bf","article-title":"Outcome for patients with malignant pleural mesothelioma referred for trimodality therapy in Western Australia","volume":"4","author":"Hasani","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bib33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","article-title":"Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection","volume":"145","author":"Sugarbaker","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","article-title":"Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma","volume":"24","author":"Richards","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1547-4127(04)00109-4","article-title":"Innovative therapies: intraoperative intracavitary chemotherapy","volume":"14","author":"Chang","year":"2004","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ejcts.2007.01.047","article-title":"Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment","volume":"31","author":"Opitz","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jtcvs.2010.09.032","article-title":"Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study","volume":"141","author":"Opitz","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00228-001-0405-6","article-title":"Estimating the starting dose for entry into humans: principles and practice","volume":"57","author":"Reigner","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10637-009-9317-6","article-title":"Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials","volume":"28","author":"Penel","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jtcvs.2019.07.073_bibE8","unstructured":"National Cancer Institute. Protocol templates and guidelines. Suggested templates for phase 1 and 2 clinical trials. Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/templates_applications.htm. Accessed September 24, 2019."}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522319316137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522319316137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:31:34Z","timestamp":1777422694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522319316137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0022522319316137"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2019.07.073","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2019.07.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}